Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease

被引:93
作者
Gai, WP
Blessing, WW
Blumbergs, PC
机构
[1] FLINDERS UNIV S AUSTRALIA, CTR NEUROSCI, DEPT PHYSIOL, ADELAIDE, SA 5001, AUSTRALIA
[2] FLINDERS UNIV S AUSTRALIA, DEPT MED, ADELAIDE, SA 5001, AUSTRALIA
[3] INST MED & VET SCI, DEPT NEUROPATHOL, ADELAIDE, SA 5000, AUSTRALIA
基金
英国医学研究理事会;
关键词
neurodegeneration; neurofilament; pathogenesis; Lewy body;
D O I
10.1093/brain/118.6.1447
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Characteristic ubiquitin-positive, tau-negative, degenerating neurites were present in brainstem regions known to be involved in idiopathic Parkinson's disease. Corresponding changes were entirely absent from controls and from the brainstems obtained from patients who had died with Alzheimer's disease, motor neuron disease and multiple system atrophy. In Parkinson's disease cases degenerating neurites were particularly striking in the dorsal motor nucleus of the vagus. in this nucleus the density of degenerating neurites was inversely related to the duration of Parkinson's disease symptoms. Some ubiquitin-positive degenerating neurites also contained neurofilament immuno-reactivity. However confocal microscopy revealed that ubiquitin and neurofilament reactivities were located in separate regions of the degenerating neurite, suggesting that proteins other than neurofilaments may be important in the process of ubiquitination. The demonstration of ubiquitin-positive degenerating neurites in routinely prepared paraffin- embedded material particularly in the dorsal motor nucleus of the vagus, could become diagnostically useful in those Parkinson's disease cases in which Lewy bodies are difficult to find. Demonstration of extensive ubiquitin-positive degenerating neurites might provide a clue to disease activity at the time of death.
引用
收藏
页码:1447 / 1459
页数:13
相关论文
共 37 条
  • [1] AN ANTIGENIC PROFILE OF LEWY BODIES - IMMUNOCYTOCHEMICAL INDICATION FOR PROTEIN-PHOSPHORYLATION AND UBIQUITINATION
    BANCHER, C
    LASSMANN, H
    BUDKA, H
    JELLINGER, K
    GRUNDKEIQBAL, I
    IQBAL, K
    WICHE, G
    SEITELBERGER, F
    WISNIEWSKI, HM
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (01) : 81 - 93
  • [2] BLESSING WW, 1995, MAY P AUSTR NZ SOC N
  • [3] AMYGDALA PATHOLOGY IN PARKINSONS-DISEASE
    BRAAK, H
    BRAAK, E
    YILMAZER, D
    DEVOS, RAI
    JANSEN, ENH
    BOHL, J
    JELLINGER, K
    [J]. ACTA NEUROPATHOLOGICA, 1994, 88 (06) : 493 - 500
  • [4] INDEXES OF OXIDATIVE STRESS AND MITOCHONDRIAL-FUNCTION IN INDIVIDUALS WITH INCIDENTAL LEWY BODY DISEASE
    DEXTER, DT
    SIAN, J
    ROSE, S
    HINDMARSH, JG
    MANN, VM
    COOPER, JM
    WELLS, FR
    DANIEL, SE
    LEES, AJ
    SCHAPIRA, AHV
    JENNER, P
    MARSEN, CD
    [J]. ANNALS OF NEUROLOGY, 1994, 35 (01) : 38 - 44
  • [5] DICKSON DW, 1990, LAB INVEST, V63, P87
  • [6] HIPPOCAMPAL DEGENERATION DIFFERENTIATES DIFFUSE LEWY BODY DISEASE (DLBD) FROM ALZHEIMERS-DISEASE - LIGHT AND ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY OF CA2-3 NEURITES SPECIFIC TO DLBD
    DICKSON, DW
    RUAN, D
    CRYSTAL, H
    MARK, MH
    DAVIES, P
    KRESS, Y
    YEN, SH
    [J]. NEUROLOGY, 1991, 41 (09) : 1402 - 1409
  • [7] PATHOLOGY OF CERTAIN MEDULLARY NUCLEI IN PARKINSONISM
    EADIE, MJ
    [J]. BRAIN, 1963, 86 (04) : 781 - &
  • [8] AGING AND PARKINSONS-DISEASE - SUBSTANTIA-NIGRA REGIONAL SELECTIVITY
    FEARNLEY, JM
    LEES, AJ
    [J]. BRAIN, 1991, 114 : 2283 - 2301
  • [10] FORNO LS, 1993, NEURODEGENERATION, V2, P19